Science Media Centre

Science Media Centre

Science Alert: Experts Respond

Parkinson’s treatment trial completed

John Kerr posted in on June 18th, 2015.

New Zealand company Living Cell Technologies (LCT) have released the results of a small trial of a new Parkinson’s Disease treatment, indicating that their procedure is safe and may improve symptoms. The company’s NTCELL product is based the around implantation of cells derived from pig brain tissue, which help to support neurological function. The results […]

NZ Parkinson’s trial on hold – experts respond

John Kerr posted in on February 20th, 2014.

An Auckland biotech company is putting its trial of an experimental Parkinson’s disease treatment on hold following the withdrawal of previous animal research. Living Cell Technologies (LCT) has suspended patient recruitment for a clinical trial testing the xenotransplantation of specially encapsulated pig-derived cells (NTCELL) as a treatment for Parkinson’s disease. Earlier research from the company had […]

NZBio: The potential of living cell therapies

Peter Griffin posted in on March 22nd, 2011.

NZBio 2011 saw an update from Professor Bob Elliot of Living Cell Technologies, which is undertaking trials in New Zealand to treat diabetes sufferers. Click below to listen to the podcast of Dr Elliot’s talk (the first few minutes are unfortunately missing)

Newsletter digest: DNA forensic pioneer, LCT’s govt funding and climate science’s future

Peter Griffin posted in on February 12th, 2010.

DNA Pioneer in SMC briefing As New Zealand forensic scientists prepare to mark 20 years of DNA testing in New Zealand the Science Media Centre is pleased to host an online briefing for journalists featuring one of the founding fathers of DNA forensics, Dr Peter Gill. As this Times article explains, Dr Gill was part […]

NZ Herald/NZPA: Pig cell implants reduce insulin for NZ patient

Peter Griffin posted in on December 4th, 2009.

The first patient to have pig islet cells transplanted as part of LCT’s Diabacell clinical trials, has been able to reduce the amount of insulin he has to take daily. An excerpt: (read in full here) “The clinical trials of the Living Cell Technologies product – pig islet cells wrapped in a seaweed-based gelatine to […]

Unlimited magazine: Two features on science

Peter Griffin posted in on October 8th, 2009.

Unlimited interviews Young Scientist of the Year, Victoria University’s John Watt, and looks at the potential for the science sector in loosening regulatory controls on scientific research, particularly in the areas of health and genetic modification of crops…

First implant of DIABACELL® successful

Peter Griffin posted in on October 8th, 2009.

Yesterday, Living Cell Technologies announced the successful first implant of its DIABECELL® in Auckland. This is the first of 8 such implants to be carried out in New Zealand as part of clinical trials for the treatment, which has been designed to normalise the blood sugar levels of people with type I diabetes.  It makes […]

Xenotransplantation and the LCT trials in New Zealand

Peter Griffin posted in on July 17th, 2009.

UPDATE: Living Cell Technologies, a New Zealand-based biotech firm, has just announced that it is commencing trials on a potentially revolutionary diabetes treatment. The treatment will be based on xenotransplantation – the transplantation of animal cells, tissues or organs into human patients. In this case, LCT has been granted approval to transplant pig islet cells […]

Copyright 2016 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy